data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Vaxart
(NASDAQ:VXRT)
$4.28
At close: Jul 6
$4.21
-0.0700[-1.64%]
PreMarket: 7:56PM EDT
Day High/Low- - -
52 Week High/Low2.49 - 10.33
Open / Close- / -
Float / Outstanding112.5M / 126.4M
Vol / Avg.- / 2.8M
Mkt Cap541.2M
P/E-
50d Avg. Price3.46
Div / Yield-
Payout Ratio-
EPS-0.2
Total Float112.5M

Vaxart (NASDAQ:VXRT), Quotes and News Summary

Vaxart (NASDAQ: VXRT)

Day High/Low- - -
52 Week High/Low2.49 - 10.33
Open / Close- / -
Float / Outstanding112.5M / 126.4M
Vol / Avg.- / 2.8M
Mkt Cap541.2M
P/E-
50d Avg. Price3.46
Div / Yield-
Payout Ratio-
EPS-0.2
Total Float112.5M
Benzinga - 6 days ago
Benzinga - Jun 3, 2022, 8:03AM
Benzinga - Jun 2, 2022, 8:32AM
Benzinga - May 19, 2022, 10:59AM
Benzinga - May 19, 2022, 8:33AM
Benzinga - May 9, 2022, 5:47PM
Benzinga - Feb 24, 2022, 5:24PM
Benzinga - Dec 17, 2021, 2:42PM
Benzinga - Dec 16, 2021, 9:05AM
Benzinga - Dec 16, 2021, 8:01AM
Benzinga - Dec 1, 2021, 8:04AM
Benzinga - Nov 29, 2021, 3:57PM
Benzinga - Nov 24, 2021, 2:27PM
Benzinga - Nov 23, 2021, 12:23PM
Benzinga - Nov 18, 2021, 4:05PM
Benzinga - Nov 18, 2021, 1:48PM
Benzinga - Nov 16, 2021, 8:06AM
Benzinga - Nov 2, 2021, 7:52AM
Benzinga - Oct 26, 2021, 8:12AM
Benzinga - Oct 12, 2021, 2:10PM
Benzinga - Oct 12, 2021, 10:20AM
Benzinga - Oct 8, 2021, 9:57AM
Sector: Health Care.Industry: Biotechnology
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-04
REV
Q1 2022Est.ActualSurprise
EPS-0.200
REV85.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Vaxart Questions & Answers

Q
How do I buy Vaxart (VXRT) stock?
A

You can purchase shares of Vaxart (NASDAQ: VXRT) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Vaxart's (VXRT) competitors?
Q
What is the target price for Vaxart (VXRT) stock?
A

The latest price target for Vaxart (NASDAQ: VXRT) was reported by B. Riley Securities on Thursday, May 19, 2022. The analyst firm set a price target for 6.00 expecting VXRT to rise to within 12 months (a possible 40.19% upside). 2 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Vaxart (VXRT)?
A

The stock price for Vaxart (NASDAQ: VXRT) is $4.28 last updated July 6, 2022, 8:00 PM UTC.

Q
Does Vaxart (VXRT) pay a dividend?
A

There are no upcoming dividends for Vaxart.

Q
When is Vaxart (NASDAQ:VXRT) reporting earnings?
A

Vaxart’s Q2 earnings are confirmed for Thursday, August 4, 2022.

Q
Is Vaxart (VXRT) going to split?
A

There is no upcoming split for Vaxart.

Q
What sector and industry does Vaxart (VXRT) operate in?
A

Vaxart is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.